• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过改变癌细胞黏附抑制转移:功能和分子研究 **注意**:以上译文仅供参考,具体翻译请根据实际情况进行调整。

Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion - Functional and Molecular Studies.

机构信息

Faculty of Chemistry, Jagiellonian University in Krakow, Gronostajowa 2, 30-387Krakow, Poland.

Department of Biophysical Microstructures, Institute of Nuclear Physics, Polish Academy of Sciences, PL-31342Krakow, Poland.

出版信息

J Med Chem. 2022 Aug 11;65(15):10459-10470. doi: 10.1021/acs.jmedchem.2c00580. Epub 2022 Jul 27.

DOI:10.1021/acs.jmedchem.2c00580
PMID:35895090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9376949/
Abstract

The effect of polypyridyl Ru(II) complexes on the ability of cancer cells to migrate and invade, two features important in the formation of metastases, is evaluated. studies are carried out on breast cancer cell lines, MDA-MB-231 and MCF-7, as well as melanoma cell lines A2058 and A375. Three Ru(II) complexes comprising two 4,7-diphenyl-1,10-phenanthroline (dip) ligands and as a third ligand 2,2'-bipyridine (bpy), or its derivative with either 4-[3-(2-nitro-1H-imidazol-1-yl)propyl] (bpy-NitroIm), or 5-(4-{4'-methyl-[2,2'-bipyridine]-4-yl}but-1-yn-1-yl)pyridine-2-carbaldehyde semicarbazone (bpy-SC) moiety attached are examined. The low sub-toxic doses of the studied compounds greatly affected the cancer cells by inhibiting cell detachment, migration, invasion, transmigration, and re-adhesion, as well as increasing cell elasticity. The molecular studies revealed that the Ru(II) polypyridyl complexes impact the activity of the selected integrins and upregulate the expression of focal adhesion components such as vinculin and paxillin, leading to an increased number of focal adhesion contacts.

摘要

研究了包含两个 4,7-二苯基-1,10-菲咯啉(dip)配体和一个 2,2'-联吡啶(bpy)或其具有 4-[3-(2-硝基-1H-咪唑-1-基)丙基](bpy-NitroIm)或 5-(4-{4'-甲基-[2,2'-联吡啶]-4-基}丁-1-炔-1-基)吡啶-2-甲酰半缩氨(bpy-SC)部分的衍生物的三个 Ru(II) 配合物对癌细胞迁移和侵袭能力的影响,这两个特征在转移的形成中很重要。研究了乳腺癌细胞系 MDA-MB-231 和 MCF-7 以及黑色素瘤细胞系 A2058 和 A375。这些低亚毒性剂量的研究化合物通过抑制细胞脱落、迁移、侵袭、穿越和再黏附,以及增加细胞弹性,极大地影响了癌细胞。分子研究表明,Ru(II) 多吡啶配合物影响选定的整合素活性,并上调粘着斑成分(如 vinculin 和 paxillin)的表达,导致粘着斑接触点数量增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/0e05fa86acdb/jm2c00580_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/87a5cc4283cf/jm2c00580_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/026273f50d27/jm2c00580_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/4dea132f9cdc/jm2c00580_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/60e0d742b1c0/jm2c00580_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/4adc35e95aeb/jm2c00580_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/822e6c4bea72/jm2c00580_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/0fc582b37299/jm2c00580_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/04edd80a30c5/jm2c00580_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/0e05fa86acdb/jm2c00580_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/87a5cc4283cf/jm2c00580_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/026273f50d27/jm2c00580_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/4dea132f9cdc/jm2c00580_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/60e0d742b1c0/jm2c00580_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/4adc35e95aeb/jm2c00580_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/822e6c4bea72/jm2c00580_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/0fc582b37299/jm2c00580_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/04edd80a30c5/jm2c00580_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def6/9376949/0e05fa86acdb/jm2c00580_0010.jpg

相似文献

1
Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion - Functional and Molecular Studies.通过改变癌细胞黏附抑制转移:功能和分子研究 **注意**:以上译文仅供参考,具体翻译请根据实际情况进行调整。
J Med Chem. 2022 Aug 11;65(15):10459-10470. doi: 10.1021/acs.jmedchem.2c00580. Epub 2022 Jul 27.
2
Impact of Polypyridyl Ru Complexes on Angiogenesis-Contribution to Their Antimetastatic Activity.多吡啶钌配合物对血管生成的影响——对其抗转移活性的贡献。
Int J Mol Sci. 2022 Jul 12;23(14):7708. doi: 10.3390/ijms23147708.
3
The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.一种多吡啶钌配合物的硝基咪唑衍生物对癌细胞和内皮细胞的生物学效应。
Metallomics. 2015 Mar;7(3):553-66. doi: 10.1039/c5mt00037h.
4
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.采用 2,2'-联吡啶、氨基酸和一氧化氮衍生物的混合配体钌(II)配合物作为潜在抗癌药物提高乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
5
Inhibition of Matrix Metalloproteinases and Cancer Cell Detachment by Ru(II) Polypyridyl Complexes Containing 4,7-Diphenyl-1,10-phenanthroline Ligands-New Candidates for Antimetastatic Agents.含4,7-二苯基-1,10-菲咯啉配体的钌(II)多吡啶配合物对基质金属蛋白酶的抑制作用及癌细胞脱离——抗转移剂的新候选物
Pharmaceuticals (Basel). 2021 Oct 1;14(10):1014. doi: 10.3390/ph14101014.
6
Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.钌(II)金属配合物的未探索特性——走向联合细胞毒性和抗转移活性。
Metallomics. 2020 May 27;12(5):784-793. doi: 10.1039/d0mt00019a.
7
The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.系列应变光致活化的 Ru(II) 多吡啶配合物对非小细胞肺癌和三阴性乳腺癌细胞的抗癌作用。
J Biol Inorg Chem. 2021 Feb;26(1):43-55. doi: 10.1007/s00775-020-01835-7. Epub 2020 Nov 22.
8
2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization.2-硝基咪唑钌多吡啶配合物作为一种新的用于癌症治疗和可视化的共轭物。
J Inorg Biochem. 2014 May;134:83-91. doi: 10.1016/j.jinorgbio.2014.02.001. Epub 2014 Feb 14.
9
Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.以多吡啶为辅助配体的钌(II)白花丹醌配合物通过抑制能量代谢和GADD45A介导的细胞周期阻滞发挥抗癌活性。
Eur J Med Chem. 2022 Jun 5;236:114312. doi: 10.1016/j.ejmech.2022.114312. Epub 2022 Mar 30.
10
In Vitro and In Silico Screening of Benzimidazole-Based Ruthenium(II) Complexes as Potent ALK Inhibitor for Cancer Prevention.基于苯并咪唑的钌(II)配合物的体外和计算机筛选作为潜在的癌症预防的 ALK 抑制剂。
Appl Biochem Biotechnol. 2023 Dec;195(12):7397-7413. doi: 10.1007/s12010-023-04435-8. Epub 2023 Mar 31.

引用本文的文献

1
Exploring the Impact of Phenanthroline-Based Glycoconjugated Ru(II) Polypyridyl Photosensitizers on Metastasis-Related Processes.探索基于菲咯啉的糖缀合钌(II)多吡啶光敏剂对转移相关过程的影响。
Chemistry. 2025 Jul 22;31(41):e202501105. doi: 10.1002/chem.202501105. Epub 2025 Jun 8.
2
Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling.含2-硫尿嘧啶衍生物的钌(II)配合物通过靶向NF-κB和Akt/mTOR信号通路抑制肝癌干细胞。
Cell Death Discov. 2024 Jun 3;10(1):270. doi: 10.1038/s41420-024-02036-w.
3
Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections.

本文引用的文献

1
Moving Ru polypyridyl complexes beyond cytotoxic activity towards metastasis inhibition.将 Ru 多吡啶配合物的活性从细胞毒性拓展到抑制转移。
J Inorg Biochem. 2022 Jan;226:111652. doi: 10.1016/j.jinorgbio.2021.111652. Epub 2021 Oct 29.
2
Inhibition of Matrix Metalloproteinases and Cancer Cell Detachment by Ru(II) Polypyridyl Complexes Containing 4,7-Diphenyl-1,10-phenanthroline Ligands-New Candidates for Antimetastatic Agents.含4,7-二苯基-1,10-菲咯啉配体的钌(II)多吡啶配合物对基质金属蛋白酶的抑制作用及癌细胞脱离——抗转移剂的新候选物
Pharmaceuticals (Basel). 2021 Oct 1;14(10):1014. doi: 10.3390/ph14101014.
3
Nanomechanics in Monitoring the Effectiveness of Drugs Targeting the Cancer Cell Cytoskeleton.
钌(II)配合物作为对抗癌症和病毒感染的有前景的双活性药物。
Pharmaceuticals (Basel). 2023 Dec 15;16(12):1729. doi: 10.3390/ph16121729.
4
New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.新型钌-桑辛素复合物通过靶向热休克蛋白 90 伴侣消除结直肠肿瘤干细胞。
Cell Death Dis. 2023 Dec 15;14(12):832. doi: 10.1038/s41419-023-06330-w.
5
Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2--(2-quinolylmethylene)aminophenol.5-氯-2-[(2-喹啉基)亚甲基]氨基苯酚与 Cu(II)、Zn(II)和 Mn(II)配合物的抗癌活性及作用模式。
Molecules. 2023 Jun 20;28(12):4876. doi: 10.3390/molecules28124876.
6
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem.三阴性乳腺癌的阳离子钌基核脂质纳米系统的临床前治疗管理。
Int J Mol Sci. 2023 Mar 30;24(7):6473. doi: 10.3390/ijms24076473.
7
Impact of Polypyridyl Ru Complexes on Angiogenesis-Contribution to Their Antimetastatic Activity.多吡啶钌配合物对血管生成的影响——对其抗转移活性的贡献。
Int J Mol Sci. 2022 Jul 12;23(14):7708. doi: 10.3390/ijms23147708.
纳米力学在监测靶向癌细胞细胞骨架药物的效果中的应用。
Int J Mol Sci. 2020 Nov 20;21(22):8786. doi: 10.3390/ijms21228786.
4
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation.细胞毒性治疗的阴暗面:放化疗诱导的细胞死亡与肿瘤再增殖。
Trends Cancer. 2020 May;6(5):419-431. doi: 10.1016/j.trecan.2020.01.018. Epub 2020 Feb 26.
5
Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.钌(II)金属配合物的未探索特性——走向联合细胞毒性和抗转移活性。
Metallomics. 2020 May 27;12(5):784-793. doi: 10.1039/d0mt00019a.
6
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.二甲双胍通过靶向 RAD51 克服三阴性乳腺癌 (TNBC) 细胞对顺铂的耐药性。
Breast Cancer Res. 2019 Oct 22;21(1):115. doi: 10.1186/s13058-019-1204-2.
7
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion.化疗对肿瘤复发和转移促进的矛盾作用。
Semin Cancer Biol. 2020 Feb;60:351-361. doi: 10.1016/j.semcancer.2019.08.019. Epub 2019 Aug 24.
8
Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions.化疗诱导的转移:分子机制、临床表现、治疗干预。
Cancer Res. 2019 Sep 15;79(18):4567-4576. doi: 10.1158/0008-5472.CAN-19-1147. Epub 2019 Aug 20.
9
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment.细胞黏附分子及其在免疫和肿瘤微环境中的作用和调控。
Front Immunol. 2019 May 22;10:1078. doi: 10.3389/fimmu.2019.01078. eCollection 2019.
10
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry.NAMI-A 和 KP1019/1339,两个标志性的钌类抗癌候选药物面对面:药物无机化学的案例研究。
Molecules. 2019 May 24;24(10):1995. doi: 10.3390/molecules24101995.